Tom Burke

Sepsis can become deadly within hours, but traditional testing may take too long for frontline triage decisions. Vail Scientific is working to change that. CEO Tom Burke will share how the company’s VSNO technology enables noninvasive screening in under two minutes, with potential to transform triage and early intervention. VSNO is a rapid, noninvasive breath-based screening device that measures exhaled biomarkers to help identify sepsis risk earlier. Beyond the device, this is a story of tackling a long-stagnant clinical challenge, translating sensing science into practical workflows, and building a company around an urgent unmet need. For medtech leaders, Vail highlights how focused innovation can reshape critical care pathways.